Bone marrow dosimetry in peptide receptor radionuclide therapy with [(177)Lu-DOTA(0),Tyr(3)]octreotate

PURPOSE: Adequate dosimetry is mandatory for effective and safe peptide receptor radionuclide therapy (PRRT). Besides the kidneys, the bone marrow is a potentially dose-limiting organ. The radiation dose to the bone marrow is usually calculated according to the MIRD scheme, where the accumulated act...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Forrer, Flavio, Krenning, Eric P., Kooij, Peter P., Bernard, Bert F., Konijnenberg, Mark, Bakker, Willem H., Teunissen, Jaap J. M., de Jong, Marion, van Lom, Kirsten, de Herder, Wouter W., Kwekkeboom, Dik J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer-Verlag 2009
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2691529/
https://ncbi.nlm.nih.gov/pubmed/19247653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-009-1072-6
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia